The first batches of the bivalent vaccine against COVID-19 are expected to arrive in January 2023,
Peruvian Health Minister Rosa Gutierrez reported on Sunday.
"We have completed all the administrative formalities. Let's understand that I have marked ten days in office (as minister), but we have done this exactly four days ago, and the bivalent vaccine should be here (in Peru) by January," she stressed.
Remarks were delivered this morning during her visit to the National Maternal Perinatal Institute (INMP) to meet the first babies born on Christmas Day.
Although she did not give an exact date for the arrival of the antigen, Gutierrez noted that it is essential for her sector to have the vaccine in order to continue protecting the population across the country.
In this regard, the government official called on the population to go to the nearest vaccination site to complete their COVID-19 vaccination schedule to avoid getting seriously ill from the virus.
"It is very important that those who have not had their third or fourth vaccine dose can do so, because the vaccine protects us from cases of serious after-effects," she said.
The Cabinet member underscored that, to date, only 25% of the population has completed their COVID-19 vaccination schedule, noting that a significant percentage of the population has not yet initiated vaccination.
What is the bivalent vaccine?
In this regard, infectious disease specialist at the National Health Institute (INS) Natalia Vargas said that bivalent vaccines contain two messenger RNA (mRNA) components of SARS-CoV-2 virus.
(END) LIT/RMB
Published: 12/25/2022